SYNERGY™ XD H7493941824500Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729981275), received between Mar 12, 2021 and Feb 23, 2024 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove2
- Break1
- Defective Device1
- Device Dislodged or Dislocated1
- Difficult to Advance1
- Failure to Advance1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 23, 2024Break; Difficult to Remove; Break; Difficult to Remove
IT WAS REPORTED THAT REMOVAL DIFFICULTY AND SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE NON-TORTUOUS AND NON-CALCIFIED LEFT MAIN CORONARY ARTERY. A 5.00 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. THE BALLOON WAS INFLATED TO APPROXIMATELY 12 ATM AND THE STENT WAS IMPLANTED WITHOUT DIFFICULTY. DURING REMOVAL AND AFTER BALLOON DEFLATION, RESISTANCE WAS NOTICED WHEN REMOVING, AND THE BALLOON BECAME LODGED WITHIN THE STENT. AT THE SECOND ATTEMPT, THE STENT BALLOON WAS SUCCESSFULLY PULLED INTO THE GUIDE CATHETER, BUT THE STENT DELIVERY SHAFT FRACTURED AND BROKE APART NEAR THE MONORAIL WIRE EXIT PORT WITHIN THE GUIDE CATHETER. THE DETACHED PORTION OF THE DEVICE WAS REMOVED INSIDE THE GUIDE CATHETER FROM THE PATIENT. IT WAS NOTED THAT VACUUM WAS APPLIED AND HELD DURING BALLOON WITHDRAWAL. PHYSICAL DAMAGE WAS OBSERVED POST-PROCEDURE, AND THE BALLOON WAS DEFLATED PRIOR TO REMOVAL. THE PROCEDURE WAS COMPLETED WITH THE ORIGINAL DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18773358 ↗InjuryOct 18, 2023Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. A 5.00 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING INSERTION OF THE DEVICE, THE STENT DETACHED FROM THE BALLOON INSIDE THE PATIENT. THE DEVICE WAS REMOVED SUCCESSFULLY AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17958069 ↗MalfunctionMar 12, 2021Difficult to Remove; Failure to Advance; Defective Device; Difficult to Advance; Difficult to Remove; Failure to Advance; Defective Device; Difficult to Advance
IT WAS REPORTED THAT DIFFICULTY REMOVAL WERE ENCOUNTERED. THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY (RCA). A 5.00 X 24MM SYNERGY XD DRUG ELUTING STENT WAS SELECTED FOR USE. THE SYNERGY XD DRUG ELUTING STENT WAS ADVANCED BUT COULD NOT CROSS THE LESION. UPON REMOVAL THE SYNERGY XD DRUG ELUTING STENT, THE STENT WAS CATCHING ON THE CATHETER. IT WAS OBSERVED THAT THE BALLOON WAS SLIGHTLY INFLATED ON EACH END OF THE STENT. THE PROCEDURE WAS COMPLETED WITH A NON-BSC STENT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11474135 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page